Viruses 2014, 6(3), 1395-1409; doi:10.3390/v6031395

Gene Therapy Targeting HIV Entry

1email and 1,2,* email
Received: 4 November 2013; in revised form: 19 February 2014 / Accepted: 26 February 2014 / Published: 21 March 2014
(This article belongs to the Special Issue Gene Therapy for Retroviral Infections)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Despite the unquestionable success of antiretroviral therapy (ART) in the treatment of HIV infection, the cost, need for daily adherence, and HIV-associated morbidities that persist despite ART all underscore the need to develop a cure for HIV. The cure achieved following an allogeneic hematopoietic stem cell transplant (HSCT) using HIV-resistant cells, and more recently, the report of short-term but sustained, ART-free control of HIV replication following allogeneic HSCT, using HIV susceptible cells, have served to both reignite interest in HIV cure research, and suggest potential mechanisms for a cure. In this review, we highlight some of the obstacles facing HIV cure research today, and explore the roles of gene therapy targeting HIV entry, and allogeneic stem cell transplantation in the development of strategies to cure HIV infection.
Keywords: HIV; gene therapy; HIV cure; HIV entry; HIV reservoir; CCR5 delta 32
PDF Full-text Download PDF Full-Text [565 KB, uploaded 21 March 2014 14:45 CET]

Export to BibTeX |

MDPI and ACS Style

Didigu, C.; Doms, R. Gene Therapy Targeting HIV Entry. Viruses 2014, 6, 1395-1409.

AMA Style

Didigu C, Doms R. Gene Therapy Targeting HIV Entry. Viruses. 2014; 6(3):1395-1409.

Chicago/Turabian Style

Didigu, Chuka; Doms, Robert. 2014. "Gene Therapy Targeting HIV Entry." Viruses 6, no. 3: 1395-1409.

Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert